Burning Rock Biotech Ltd balance sheet

At the end of fiscal 2025, Burning Rock Biotech Ltd had total assets of $117m, total liabilities of $40.8m and shareholders' equity of $76.5m. It held $68.4m in cash against $243,097 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Burning Rock Biotech Ltd: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	14	14	290	225	131	87	71	68
Receivables	—	13	14	14	16	18	21	24
Inventory	—	8	10	19	19	10	7	7
Total current assets	—	102	387	286	183	125	106	106
Total assets	—	122	408	358	230	146	121	117
Accounts payable	—	2	5	10	7	3	5	6
Deferred revenue (current)	—	7	11	22	21	18	16	15
Total current liabilities	—	24	37	58	60	37	36	35
Short-term debt	—	0	1	0	0	—	—	—
Long-term debt	—	3	0	—	—	—	0	0
Total debt	0	3	1	0	0	0	0	0
Total liabilities	—	30	37	68	62	38	42	41
Shareholders' equity	−88	−128	371	290	168	108	80	77
Non-controlling interests and other (assets − liabilities − equity)	—	219	—	—	—	—	—	—
Shares outstanding	—	3m	—	—	—	—	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BNR vs CDXS BNR vs XGN BNR vs PSNL BNR vs HBIO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Burning Rock Biotech Ltd's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Burning Rock Biotech Ltd.